4C Medical Technologies announced today that it commenced enrollment in its ATLAS pivotal trial evaluating its AltaValve system. ATLAS (a transseptal left atrial system for the treatment of mitral regurgitation, or MR) evaluates AltaValve’s safety and efficacy. Participants in the study have moderate-to-severe or severe MR and are unsuitable for surgery or transcatheter edge-to-edge repair […]
4cmedical
4C Medical wins dual FDA breakthrough nods for mitral valve replacement device
4C Medical Technologies announced today that the FDA granted breakthrough device designation for its AltaValve system. The company received designations for two therapeutic indications for the transcatheter mitral valve replacement (TMVR) device. It can look at the valve for the treatment of moderate-to-severe or severe mitral regurgitation (MR). The company can also evaluate AltaValve in […]
4C Medical Technologies completes $10M financing
4C Medical Technologies announced that it completed an over-subscribed convertible note financing worth $10 million in gross proceeds. Minneapolis-based 4C Medical Technologies said in a news release that an unnamed China-based venture firm led the financing round. The company plans to use the net proceeds from the financing to fund the continued development of its […]
4C Medical pulls in $8m
4C Medical Technologies secured more than $8 million in an equity offering it hopes will reach the $20 million mark. The Maple Grove, Minn.-based company raised nearly $8.2 million in the offering, with $11.8 million remaining to be sold, according to an SEC Form D filed today. Forty-five unnamed investors have contributed to the offering. […]
Minnesota’s medtech industry raised $90M in Q3 2018
Investments in Medical Alley medtech companies, which had dipped in recent years, have made a comeback, according to the Minnesota trade association. Device companies raised $90 million in the third quarter, pushing the year-to-date total to nearly $200 million raised by 33 companies. Q3’s largest raises in medtech included Urotronic ($26 million, including $20M in Series B funds), 4C Medical ($17 million), […]
4C Medical raises $17m Series A for mitral repair device
4C Medical Technologies said today that it raised a $17 million Series A round for the AltaValve transcatheter mitral valve replacement device it’s developing. Brooklyn Park, Minn.-based 4C Medical, which drummed up a $9 million seed round in July 2017, said its latest private placement was led by an undisclosed “multi-national strategic investor” and included existing […]
8 companies commercializing transcatheter mitral valve replacements
Transcatheter mitral valve replacement is a new frontier in the cardio device field, with big legacy medical device companies including Edwards Lifesciences, Medtronic and Abbott spending hundreds of millions of dollars on companies in the space. Much different from transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR) has been mostly experimental. TMVR is used […]
20 medical device startups you need to know
There’s a lot of excitement these days around digital health. But there are actually many medical device startups out there in other spaces that continue to push the overall boundaries of medtech. From neuromodulation to drug delivery, surgical robotics and more, here’s a roundup of 20 medical device startups catching the eye of Medical Design […]
TMVR dev 4C Medical raises $9m
Structural heart disease device maker 4C Medical said today it completed a private placement of unsecured convertible promissory notes, raising approximately $9 million to help support development of its transcatheter tech designed to treat mitral regurgitation. The financing was led by Canadian angel network Anges Québec, the Brooklyn Park, Minn.-based company said. “We are excited […]
